Cornea
Outcome of Cenegermin in the Treatment of Neurotrophic Keratopathy.
Golshan Latifi, Piseth Dalin Chea, Saba Al-Hashimi, Seyed Reza Ghaffari, Anthony J Aldave, Sophie X Deng, Simon S M Fung
Published: 202510.1097/ICO.0000000000004024
Abstract
PURPOSE: To evaluate the efficacy of cenegermin 0.002% in neurotrophic keratopathy (NK). METHODS: This is a single-center retrospective case series. Data including demographic information, clinical characteristics, and staging of NK at baseline and 8…
Preview only. Read the full abstract at the source